Latest news

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

BioSeed Capital reinforced its presence in the TTS Latin America conference held in Miami

 After the rewarding experience in the past two annuals of the TTS Global Initiative in Medellín and Santiago de Compostela, BioSeed Capital took part in the latest conference as part of the international speakers.

BioSeed Capital opens new office in London and becomes part of one of the most important centers worldwide in innovation and access to capital

The last November BioSeed Capital with headquarters in the Parc Científic of Barcelona established a new office in London to get access to UK’s market, one of the most powerful worldwide in healthcare startups, as well as in pharmaceutical firms.

Barcelona has been the first city hosting ENABLE symposium, an European initiative for young scientists included in the “Celebrating European Science” section of the EU’s Horizon 2020 Program

 More than 300 PhD and Postdoctoral students from all over Europe have met in the first European symposium of Biomedicine held in the Palauet Casades, in the centre of Barcelona. The conference, entitled "Breaking down complexity. Innovative models and techniques in Biomedicine" connected the students with new career opportunities in the world of science unexplored for most researchers.

The Summer Charity Cocktail supports companies researching in pediatric cancer, under the first Childhood Cancer Innovation Award

The charity event, organized by the Biotechnology Business Institute in collaboration with the Richi Childhood Cancer Foundation, raised money from the attendees to boost innovative companies researching in pediatric oncology.

The Biotechnology Business Institute finishes a new master’s edition under the first year of the Discover & Transfer educational agreement

Last week we concluded the master’s edition 2017-2018. After nine months of hard work, board of professors, students and managing directors of the Biotechnology Business Institute joined together the presentation of the final projects in the framework of the first year of the educational agreement Discover & Transfer.